JB

James Barrie

Nexalis Therapeutics Ltd | Company Secretary, Executive Director
Mr Barrie is a Company Secretary and Director and brings experience as a Director of several listed and unlisted pharmaceutical, bio-tech and med-tech companies.

Company and Roles

Company
Title
Tenure
Since
NX1
NX1
Nexalis Therapeutics Ltd
  • Company Secretary
  • Executive Director
2yrs, 10mthAug 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
NX1
NX1
Nexalis Therapeutics Ltd
12/05/260524,79225,000N/A
HIQ
HIQ
30/01/2670,00015,503,345303,540N/A
IRX
IRX
06/02/250492,792N/AN/A
BOA
BOA
29/11/24259,782259,09037,630N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
HIQ
HIQ
07/10/25
Buy
100,000$0.021$2,100On-market trade
HIQ
HIQ
27/06/25
Issued
607,095$0.022$13,356Rights issue
HIQ
HIQ
27/06/25
Issued
303,540$0.017$5,160Rights issue
HIQ
HIQ
17/12/24
Issued
656,250$0.040$26,250Director remuneration
IRX
IRX
16/12/24
Issued
492,792$0.033$16,500Director remuneration